Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus

被引:220
作者
Chen, ZN
Mi, L
Xu, J
Yu, JY
Wang, XH
Jiang, JL
Xing, JL
Shang, P
Qian, AR
Li, Y
Shaw, PX
Wang, JW
Duan, SM
Ding, J
Fan, CM
Zhang, Y
Yang, Y
Yu, XL
Feng, Q
Li, BH
Yao, XY
Zhang, Z
Li, L
Xue, XP
Zhu, P
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Clin Immunol, Xian 710032, Peoples R China
[2] Fourth Mil Med Univ, Dept Cell Biol, Xian 710032, Peoples R China
[3] Acad Mil Med Sci, Inst Basic Med Sci, Beijing, Peoples R China
[4] Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, Beijing, Peoples R China
[5] Univ Calif San Diego, Dept Mol Med, San Diego, CA 92103 USA
基金
中国国家自然科学基金;
关键词
D O I
10.1086/427811
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To identify the function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome (SARS) coronavirus (CoV), we analyzed the protein-protein interaction among HAb18G/CD147, cyclophilin A (CyPA), and SARS-CoV structural proteins by coimmunoprecipitation and surface plasmon resonance analysis. Although none of the SARS-CoV proteins was found to be directly bound to HAb18G/CD147, the nucleocapsid (N) protein of SARS-CoV was bound to CyPA, which interacted with HAb18G/CD147. Further research showed that HAb18G/CD147, a transmembrane molecule, was highly expressed on 293 cells and that CyPA was integrated with SARS-CoV. HAb18G/CD147-antagonistic peptide (AP)-9, an AP of HAb18G/CD147, had a high rate of binding to 293 cells and an inhibitory effect on SARS-CoV. These results show that HAb18G/CD147, mediated by CyPA bound to SARS-CoV N protein, plays a functional role in facilitating invasion of host cells by SARS-CoV. Our findings provide some evidence for the cytologic mechanism of invasion by SARS-CoV and provide a molecular basis for screening anti-SARS drugs.
引用
收藏
页码:755 / 760
页数:6
相关论文
共 36 条
[1]  
Bian HJ, 2000, WORLD J GASTROENTERO, V6, P348
[2]  
BISWAS C, 1995, CANCER RES, V55, P434
[3]   Lessons from SARS [J].
Bloom, BR .
SCIENCE, 2003, 300 (5620) :701-701
[4]   Redistribution of cyclophilin A to viral factories during vaccinia virus infection and its incorporation into mature particles [J].
Castro, APV ;
Carvalho, TMU ;
Moussatché, N ;
Damaso, CRA .
JOURNAL OF VIROLOGY, 2003, 77 (16) :9052-9068
[5]  
Chen Z, 1990, MONOCLONAL ANTIBODIE, V8, P11
[6]   Application of cell engineering technology to the tumour immunotherapeutic drug: A review [J].
Chen, ZN ;
Xing, JL ;
Bian, HJ ;
Mi, L ;
Jiang, JL .
CELL BIOLOGY INTERNATIONAL, 2001, 25 (10) :1013-1015
[7]  
Chen ZN, 1999, J CELL MOL IMMUNOL, V15, P34
[8]  
CHEN ZN, 2003, Patent No. 0300451
[9]  
CHEN ZN, 2003, Patent No. 030781469
[10]  
CHEN ZN, 2003, J TUMOR MARKER ONCOL, V18, P5